Welcome to Let’s talk antitrust, our video series in which members of Norton Rose Fulbright’s antitrust and competition practice and leading competition law expert Richard Whish KC discuss notable developments in EU and UK competition law. In this second series of videos for 2022 we provide insights into five key areas.


Let’s talk antitrust videos

Seeking comfort: The new EU Informal Guidance Notice

Video

Seeking comfort: The new EU Informal Guidance Notice

Global | October 31, 2022

Antitrust and competition

The EU Google Android appeal: Exclusionary practices in the digital sector

Video

The EU Google Android appeal: Exclusionary practices in the digital sector

Global | October 31, 2022

Antitrust and competition

The Compare The Market appeal: MFN clauses and competition law

Video

The Compare The Market appeal: MFN clauses and competition law

Global | October 31, 2022

Antitrust and competition

CMA warning and advisory letters: What do you need to know?

Video

CMA warning and advisory letters: What do you need to know?

Global | October 31, 2022

Antitrust and competition

"Below threshold" mergers, jurisdictional creep and abuse of dominance

Video

"Below threshold" mergers, jurisdictional creep and abuse of dominance

Global | October 31, 2022

Antitrust and competition

Contacts

Alexandra Rogers
Alexandra Rogers
Partner; Head of Brussels
Email
alexandra.rogers@nortonrosefulbright.com
T: +32 (2) 2376199
Mark Daniels
Mark Daniels
Knowledge Of Counsel
Email
mark.daniels@nortonrosefulbright.com
T: +44 20 7444 5872
Shaha El-Sheemy
Shaha El-Sheemy
Counsel
Email
shaha.el-sheemy@nortonrosefulbright.com
T: +44 (20) 74445897
Ian Giles
Ian Giles
Head of Antitrust and Competition, Europe, Middle East and Asia
Email
ian.giles@nortonrosefulbright.com
T: +44 (20) 74443930

Practice areas:

Recent publications

Publication

Understanding the impact of Medicare Advantage changes on providers

The Centers for Medicare and Medicaid (CMS) recently released important policy updates for the Medicare Advantage program, providing critical insights for providers into the new administration’s views on the Medicare Advantage program.

United States | April 16, 2025

Healthcare
biotech test tubes

Publication

Strategic asset search and evaluation in biopharma

Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

United States | April 16, 2025

Life sciences and pharmaceuticals
Why SPACs offer a robust alternative to IPO market amidst looming global trade war

Publication

SPACs offer alternative to IPO market amid looming global trade war

President Trump’s recent tariffs appear to have direct implications for initial public offering (IPO) activity in what was forecasted to be a blockbuster year for such markets.

United States | April 15, 2025

Mergers and acquisitions
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now